On February 18, 2021 Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, reported that Chairman, Chief Executive Officer and President, Kevin Hrusovsky, will be presenting at the 10th Annual SVB Leerink Global Healthcare Conference, being held virtually from February 22 – 26, 2021 (Press release, Quanterix, FEB 18, 2021, View Source [SID1234575296]). Hrusovsky’s presentation will take place on Friday, February 26, at 9:20 a.m. EST.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Attendees can access the public webcast at View Source or by visiting the News & Events page within the Investors section of the Quanterix website at View Source Replays of the webcast will be available on the Quanterix website for 90 days following the conference.

On February 18, 2021 Ashvattha Therapeutics, a clinical-stage biotech company focused on the development of novel hydroxyl dendrimer therapeutics (HDTs) to treat unmet medical needs in oncology, ocular and inflammatory diseases, reported that Jeffrey Cleland, Ph.D., Chairman, CEO & President, is scheduled to attend and present corporate updates at the following investor conferences (Press release, Ashvattha Therapeutics, FEB 18, 2021, View Source [SID1234575295]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

10th Annual SVB Leerink Global Healthcare Conference on Tuesday, February 23 – Private Company Exhibition 1×1 Meetings
H.C. Wainwright Global Life Sciences Conference on Friday, March 5 at 4:00 PM ET. Prerecorded presentation available starting on Tuesday, March 9 at 7:30 a.m. ET (4:30 a.m. PT)
"We are excited to present at these upcoming conferences and give investors an update on our pipeline. We have made extensive progress on our lead program, OP-101, with Phase 2 in severe COVID-19 patients completing enrollment. Our second program, D-4517, for subcutaneous treatment of wet AMD is progressing through IND enabling studies, and demonstration of imaging for brain tumors and brain metastases along with a robust preclinical oncology pipeline," said Jeffrey Cleland, Ph.D., Chairman, CEO & President, Ashvattha Therapeutics.

The webcasts will be accessible in the News section of the Ashvattha Therapeutics website at View Source

On February 18, 2021 Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) reported that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will present at the 10th Annual SVB Leerink Global Healthcare Conference at 3:40 p.m. ET Friday, February 26, 2021 (Press release, Aldeyra Therapeutics, FEB 18, 2021, View Source [SID1234575294]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation will be available on the investor relations page of the company’s corporate website at View Source After the live webcast, the event will remain archived on the Aldeyra Therapeutics website for 90 days.

On February 18, 2021 Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) reported that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021 at 4:20 PM ET (Press release, Deciphera Pharmaceuticals, FEB 18, 2021, View Source [SID1234575293]). The conference will be held in a virtual meeting format.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the event will be available on the "Events and Presentations" page in the "Investors" section of the Company’s website at View Source A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

On February 18, 2021 AVEO Oncology (Nasdaq: AVEO) reported that Michael Bailey, president and chief executive officer of AVEO, will participate in a fireside chat at the 2021 SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 3:00 p.m. Eastern Time (Press release, AVEO, FEB 18, 2021, View Source [SID1234575292]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the fireside chat can be accessed by visiting the investors section of the Company’s website at www.aveooncology.com. A replay of the webcast will be archived for 30 days following the presentation date.